Mission & Vision

Brain diseases such as Alzheimer’s and Parkinson’s are among the hardest conditions to treat, because so few medicines can reach the brain. Kurve exists to close that gap. Our nose-to-brain technology has been used in 22 human clinical trials and featured in 27 published studies, and we’re working to turn the tide on CNS disease.

Harvard Medical School
Johns Hopkins Medicine
Department of Defense
University of Missouri
Rutgers RWJMS
Mount Sinai
Wake Forest University

To put it simply: we do this because we can and because we have to.

Our Mission and Vision

Our mission is to help as many people as we possibly can in their fight with systemic and neurodegenerative disorders. Our hope is that these complex debilitating disorders may have a solution when paired with the right medication and the right technology. Our goal is to enhance the quality of life for patients and provide a solution where their past treatments have failed them–to give people a renewed sense of hope for the future.

Our Mission

Interested in ViaNase™?

ViaNase™ is available through Kurve’s clinical studies and FDA expanded access (compassionate use). Tell us who you are and we’ll guide you to the right route.

Interested in ViaNase